Navigation Links
ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology
Date:5/17/2010

span class="xn-chron">September 2008, AdreView was approved by the FDA for the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests.  In the United States, it is not currently approved for use in cardiac imaging.

AdreView is approved in Germany, France, Great Britain, Spain, Belgium, Holland, Denmark, and Norway for the functional assessment of the cardiac sympathetic innervation.

Important Safety Information for AdreView

Hypersensitivity reactions have followed AdreView administration. Have anaphylactic and hypersensitivity treatment measures available prior to AdreView administration. AdreView contains benzyl alcohol (10.3 mg/mL) which may cause serious reactions in premature or low birth-weight infants. Patients with severe renal impairment may have increased radiation exposure and decreased quality of AdreView images. Failure to block thyroid iodine uptake may result in iodine 123 accumulation in the thyroid. Drugs which block norepinephrine uptake or deplete norepinephrine stores may decrease AdreView uptake in neuroendocrine tumors. When medically feasible, stop these drugs before AdreView administration and monitor patients for withdrawal signs and symptoms.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing tec
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
2. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
3. 3M and CitiusTech to Integrate 3M Healthcare Data Dictionary With CitiusTechs BI-Clinical Healthcare Business Intelligence Framework
4. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
5. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
6. Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes
7. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
8. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
9. US HIFU Receives Unanimous Approval to Continue the Clinical Investigation of High Intensity Focused Ultrasound (HIFU) for Treatment of Prostate Cancer
10. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
11. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or the ... announced today that Dr. Robert Grieve , ... Jason Napolitano , executive vice president and chief financial ... which is being held May 30, 2013 in ... The Company,s presentation is scheduled to begin ...
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... CHESTERBROOK, Pa. , May 24, 2013  Auxilium ... that executive management will participate in the Deutsche Bank ... the Westin Boston Waterfront Hotel.  Mr. Adrian ... scheduled to present an overview of the Company and ... May 29, 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4
... Campath May Lead to Overall Survival in Patients with Poor ... FRANCISCO, Dec. 9 Bayer HealthCare Pharmaceuticals Inc. today announced ... showed activity in high-risk chronic lymphocytic leukemia (CLL) patients who ... 50th Annual Meeting of the American Society of Hematology in ...
... 8 Millennium: The Takeda Oncology Company today ... of patients from the large, international Phase III ... with previously untreated multiple myeloma given VELCADE, melphalan ... efficacy in all patient sub-groups, including those with ...
Cached Medicine Technology:Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
(Date:5/24/2013)... Just about any bodyweight training program includes a variety of ... Dallas, GA that uses a variety of bodyweight conditioning circuits ... used enough. , “The medicine ball pushup is ... By keeping your hands on a medicine ball, the core ... much harder than a standard pushup. This unique bodyweight chest ...
(Date:5/24/2013)... 24, 2013 For the second consecutive ... Fresh Express Café to treat Tabitha Meals on Wheels ... their door. More than 400 meal recipients recently enjoyed ... restaurants, along with the rest of a well-balanced, nutritious ... to partner with the Tabitha Meals on Wheels team,” ...
(Date:5/24/2013)... have today released updated guidelines on Hormone Replacement Therapy ... the benefits and the risks. The new guidelines appear ... published by SAGE. , Over the last 11 ... of youth" to being considered extremely risky and only ... of the Women,s Health Initiative (WHI) trial in 2002, ...
(Date:5/24/2013)... Bridal Buy , a leading wedding ... 2013 bridesmaid dresses are available in its wedding ... featured as fine fabrics, elegant beading, and exquisite embroidery. ... and an eye for detailed designs. However, our lace ... life from patterns and the hands of dressmakers,” said, ...
(Date:5/24/2013)... Psoriasis treatment cream has been released online for ... registered company is now offering its natural solution to ... infected skin. , Dermasis has launched its new psoriasis ... cream is designed to offer immediate relief to those ... red skin often caused by psoriasis outbreaks. This new ...
Breaking Medicine News(10 mins):Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2Health News:Runza® Delivers Sandwiches, Draws Smiles from Tabitha Meals on Wheels Clients 2Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2
... , SAN DIEGO, July 21 ... Anakam.TFA(R) Two-Factor Authentication as the enterprise authentication tool for ... to help the VA provide more veteran-centric benefit and ... cost-effective citizen-facing two-factor authentication solution delivered through multiple channels ...
... , , , ... historic show of unity, advocates for all the health Millennium Development Goals ... commitments to health by chronically underfunding programs for AIDS, TB, maternal and ... globe. , , The coalition of ...
... , BALTIMORE, July 21 Stayhealthy, Inc., a leader ... take control of their health, and Innovative Wellness Solutions a leader ... have reached an agreement to bring a powerful new solution to ... , , Wellness in the workplace ...
... SHENZHEN, China, July 21 /PRNewswire-Asia-FirstCall/ -- ... the,Company has changed its name to "BioPharm Asia, Inc." ... place in the next three to four weeks,in accordance ... name change to BioPharm Asia, Inc. will be reflected ...
... , , MONROVIA, Calif., July ... developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that ... Division of Bioresearch Monitoring that the restrictions of the "integrity hold" put ... The removal of the integrity hold enables the FDA to resume ...
... , , NEW YORK, July 21 ... cleanse Food & Wine Magazine recently dubbed ... State by announcing today that it will offer free delivery to anywhere in ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090721/LA49137 ) , , ...
Cached Medicine News:Health News:Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 2Health News:Department of Veterans Affairs Selects Anakam to Provide Trusted Authentication as Part of Its Overall Identity Management Strategy 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 2Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 4Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 5Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 6Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 7Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 8Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 3Health News:Domain Registration Corp. Announces Name Change to 'BioPharm Asia, Inc.' 2Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 2Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 3Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 4Health News:Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume 5Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 2Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 3
5mSports™ is the handheld version of 5 Minute Sports Medicine Consult, your favorite reference for on-field and off-field treatment of sports related problems....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
... the essential information that every intern ... wards, including the neurologic history and ... neuroimaging techniques and diagnostic tools, and ... dizziness, and ataxia, acute vision loss, ...
... all-original guide prepared specifically for ... from "PocketMedicine/Internal Medicine", it will ... those training in the field, ... are frequently the first to ...
Medicine Products: